The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty:

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDiakonie-Klinikum Stuttgart

About this trial

The aim of this study is to investigate the analgesic efficacy of the pericapsular nerve group (PENG) block during the implantation of hip endoprostheses. The study is designed as a prospective randomized double-blind study and the study participants were randomized into 2 arms and either 20 ml ropivacaine 0.5% (verum group) or 20 ml physiological saline solution (placebo group) will be applied.

Eligibility criteria

Qualifiers

planned cementless hip TEP operation for primary coxarthrosis via minimally invasive anterolateral approach using the identical implant system (Taperloc stem, Plamafit cup)

Patient capable of giving consent

Informed consent has been obtained

age > 18 years

Disqualifiers

Refusal to participate in the study

Regular use of opioids

Known chronic pain symptoms

Infections in the area of the puncture site

Trial design

Treatments tested in this trial

  • Ropivacaine
  • Physiological saline

Treatment groups

110 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Diakonie-Klinikum Stuttgart

Lead sponsor

University Hospital Tuebingen

Collaborator